Genomics

Dataset Information

0

24h-response to bevacizumab erlortinib in non-small cell lung cancer from blood-based exon array profiling


ABSTRACT: The mechanisms of action of the combined targeted therapy bevacizumab erlotinib in late stage non-squamous non-small cell lung cancer was investigated by means of whole genome exon arrays. mRNA from peripherial blood was extracted at baseline and 24h after initiation of the therapy and hybridized on Affymetrix Human Exon 1.0 ST Arrays

ORGANISM(S): Homo sapiens

PROVIDER: GSE61676 | GEO | 2016/12/31

SECONDARY ACCESSION(S): PRJNA261816

REPOSITORIES: GEO

Similar Datasets

2013-07-30 | GSE37138 | GEO
| E-GEOD-37138 | biostudies-arrayexpress
2013-01-03 | GSE19862 | GEO
| E-GEOD-19862 | biostudies-arrayexpress
2013-06-07 | GSE47706 | GEO
| E-GEOD-45161 | biostudies-arrayexpress
2008-09-15 | GSE11360 | GEO
2013-07-01 | GSE45161 | GEO
2010-09-10 | GSE23141 | GEO
| E-GEOD-25698 | biostudies-arrayexpress